Brain, metabolism, nutrition, and the molecular evidence behind the headlines.
Clinical labels group people by symptoms. Molecular biomarkers group patients by shared biology, revealing therapeutic signals that broad diagnoses can hide.
Hypertension, diabetes, dyslipidemia, atherosclerosis — the conditions your cardiologist treats to protect your coronary arteries also destroy the tiny vessels feeding your brain, often a decade before the first memory symptom appears.
Food rewrites your molecular biology three times a day. The exposome is the totality of what your biology has been exposed to — and its record is written in your metabolome, not your genes.
In 1945, an American scientist arrived in Naples and found something he didn't expect. The Seven Countries Study, what Keys ate in Cilento, and what the molecular biology now reveals.
Alzheimer's, Parkinson's, MS, myelin, APOE4, endocannabinoids, ketones, DHA, and the lipid biology of the aging brain.
One missing acid enzyme backs up its substrate — but lipids never accumulate alone. Gangliosides, cholesterol, and BMP pile up as secondary storage. The lyso-lipid biomarkers, and which diseases we can treat versus only measure.
Every cell type in the brain runs a distinct lipid economy. A landmark review maps astrocytes, neurons, microglia, and oligodendrocytes — with immediate implications for neurodegeneration.
Semaglutide failed EVOKE. Liraglutide reduced brain volume loss 50% in ELAD. Real-world data shows 40–50% dementia risk reduction. The mechanism is neuroinflammation — not weight loss.
The Alzheimer's brain stops using glucose efficiently — measurable two decades before symptoms. BHB bypasses this block, suppresses NLRP3, and activates neuroprotective gene programs.
Up to 40% of synaptic membrane fatty acids are DHA. It is not a supplement — it is the structural lipid that makes rapid, reliable synaptic transmission physically possible.
Lipid-laden GPNMB+ microglia producing oxylipins drive chronic lesion expansion in secondary progressive MS. MAGL inhibition rescues lesion recovery. CSF oxylipins as biomarkers.
George Bartzokis proposed that Alzheimer's begins not with amyloid but with the slow unraveling of myelin. Two decades later, the evidence keeps piling up on his side.
APOE4, TREM2, GBA — the genes carrying highest risk for Alzheimer's and Parkinson's disproportionately encode lipid enzymes and transporters. Lipid dysregulation is upstream.
One gene. Two organs. One lipid biology. APOE4 drives neurodegeneration and vascular disease simultaneously through impaired cholesterol transport and defective membrane lipid delivery.
GBA1, LRRK2, GRN, C9orf72 — every major genetic risk for Parkinson's and FTD converges on the same organelle. Lysosomal lipid trafficking failure is the mechanism, not the consequence.
Anandamide, 2-AG, OEA, PEA — lipid signals synthesized on demand from membrane phospholipids. FAAH and MAGL are the therapeutic targets. The complete endocannabinoid biology.
Ceramide accumulation, plasmalogen depletion, neuroferroptosis, DHA deficiency — four lipid failure modes converging on the same vulnerable membranes across AD, PD, ALS, and MS.
BMP in urine tracks LRRK2 kinase activity. GluSph in plasma tracks GBA1 dysfunction. The first lipid-based precision biomarker framework for Parkinson's stratification.
Long-term DHA supplementation preserves the meningeal lymphatic system — reducing tau and amyloid accumulation a decade before symptoms. A new explanation for fish oil and brain aging.
DHA, plasmalogens, endocannabinoids — the brain's critical lipids are manufactured in the liver, gut, and periphery. When those supply chains fail, neurodegeneration follows.
Plasma p-tau217 detects Alzheimer's pathology with AUC 0.93–0.96 from a standard blood draw — 10–15 years before symptoms. Mass spectrometry made it possible.
Anandamide — your brain's natural cannabis-like lipid — is significantly reduced in Alzheimer's disease. Here's what that means and where the research is heading.
The DHA in your brain didn't swim there from your last salmon dinner. Your liver made it — and when that process breaks down, your brain feels it decades later.
How GLP-1 receptor agonists rewrite lipid biology across adipose, liver, brain, and heart — and their emerging role in dementia prevention.
Not weight loss drugs — systemic lipid metabolism reprogrammers. They remodel adipose, suppress hepatic VLDL export, activate astrocyte fatty acid oxidation, and inhibit NLRP3.
MASLD affects 38% of adults globally. The danger is not triglyceride storage — it is the ceramides and DAGs that build up when lipid traffic exceeds capacity.
PPAR agonists delivered directly to adipose tissue macrophages via lipid nanoparticles reversed obesity, insulin resistance, and liver fat in vivo.
Beyond LDL — ceramides, Lp(a), oxidized phospholipids, the omega-3 index, vascular dementia, and RNA therapeutics transforming cardiovascular risk.
Half of all heart attacks occur in people with normal LDL. The field is moving toward ceramides, Lp(a), oxidized phospholipids, and spatial lipidomics of plaques.
Lp(a) affects 1.4 billion people. Genetically determined, immovable by statins, 5–6× more atherogenic per mole than LDL. RNA therapies achieving 80–98% reduction are in Phase 3.
A high omega-6/omega-3 ratio predicts 26% higher all-cause mortality and 31% higher CVD mortality in 85,000 UK Biobank participants. Most clinicians have never ordered it.
24S-hydroxycholesterol protects neurons. 27-hydroxycholesterol drives neurodegeneration. CYP46A1 is the druggable target. The most important sterol biology is in neurons.
Hypertension, diabetes, dyslipidemia, atherosclerosis — the conditions your cardiologist treats also destroy the tiny vessels feeding your brain, often a decade before the first memory symptom.
Ferroptosis, tumor lipid addiction, immune synapse remodeling, CAR-T engineering, and the lipid logic of cancer metabolism and immunotherapy.
Three interlocking papers: FSP1 is essential in living tumors, guards lipid droplet neutral lipids from peroxidation, and is controlled by vitamin B2.
ACSL4 drives metastasis via PUFA membrane remodeling. FASN builds membranes for proliferation. FSP1 shields cells from ferroptotic death. The full lipid addiction of cancer, mapped.
CD28.zeta CAR-T forms brief lipid raft-rich synapses and kills fast. 4-1BB.zeta forms lengthy synapses and kills slowly. Membrane lipid dynamics encode CAR-T fate.
T cells, sphingolipids, the checkpoint-metabolism interface, immune aging, and the lipid battlefield of cancer immunology.
A prostaglandin-degrading enzyme (15-PGDH) increases in arthritic joints — blocking it regenerates cartilage. The same PGE2 pathway implicated in tumor immune evasion.
Membrane ecosystems, lipid droplets, GPCRs, gut–brain axis, SPMs, and the molecular machinery of lipid-driven signaling.
From van Meer and de Kroon's lipid map to modern organelle lipidomics — cardiolipin, BMP, phosphoinositides, and lipid rafts as functional readouts of cellular health.
Molecular dynamics simulations reveal membrane lipids entering GPCR binding pockets, stabilizing hidden allosteric sites, creating lateral gateways invisible to crystallography.
Resolvins, protectins, maresins, lipoxins — omega-3-derived SPMs that actively shut down inflammation and restore tissue homeostasis. Active resolution, not immunosuppression.
Two landmark 2026 papers reveal lipid droplets as heterogeneous, organelle-communicating metabolic hubs — mitochondria hijack their own protein import machinery for energy.
Membrane proteins do not float in a uniform lipid sea. They are surrounded by selective, dynamic lipid ecosystems that determine their assembly, conformation, and function.
Bacteroides sphingolipids calibrate immunity. Microbial bile acids signal through FXR and TGR5. Microbial lipids reach the brain via four routes.
Ceramides rise. Plasmalogens fall. Ether phospholipids mark exceptional longevity in centenarians. Large-scale lipidomics is building the first molecular clock of biological aging.
Food rewrites your molecular biology three times a day. The exposome is the totality of what your biology has been exposed to — and its record is written in your metabolome.
Lipid nanoparticles, spatial lipidomics, mass spectrometry, AI multi-omics — the tools rewriting what is measurable, druggable, and deliverable.
Single-cell genomics, fluid multi-omics, spatial transcriptomics, and spatial lipidomics — integrated by deep graph neural networks — breaking the target discovery bottleneck.
Peptide ionizable lipids, SORT chemistry, and protein corona engineering have broken the liver monopoly on mRNA delivery — opening lung, spleen, thymus, and bone marrow.
For the first time, researchers can identify which specific lipids bind to which specific proteins inside living cells. A new tool that reframes membrane biology.
A mass spectrometer can detect thousands of molecules in a single drop of blood. Here's how it works — and why it is changing medicine, diagnostics, and our understanding of biology.
Clinical subtypes are biologically heterogeneous. Molecular subtypes are biologically coherent. The case for molecular-driven patient stratification.
From target identification to precision medicine — how small-molecule readouts of real-time biology are reshaping the entire drug development pipeline.
The molecular science of what we eat — OEA and satiety, the omega-3 index, dietary fat policy, the Mediterranean diet, and the biology of exceptional longevity.
A 2025 review of 18 studies found the Mediterranean diet delays cognitive aging by up to 3.5 years. A lipid scientist explains what's actually happening at the membrane level.
Fish oil, vitamin D, vitamin A, CoQ10 — the most widely consumed supplements in the world are all lipids. Every one has a validated blood biomarker. Almost nobody taking them has measured theirs.
Oleoylethanolamide — produced in your small intestine within 30 minutes of eating olive oil — activates PPAR-alpha and signals satiety via the vagus nerve.
The 2025–2030 Dietary Guidelines were released January 7, 2026. Fat was the most controversial topic. A lipid scientist's review of what the evidence actually supports.
In 1945, an American scientist arrived in Naples and found something he didn't expect. The Seven Countries Study, what Keys ate in Cilento, and what the molecular biology now reveals.
The only nut with significant omega-3 content — but that is the least interesting thing about them. Ellagitannins converted by gut bacteria to urolithins, ALA, and dietary melatonin.
From the Amalfi Coast — centuries of tradition combining exceptional flavor with powerful nutrition. The fermentation biochemistry, EPA and DHA content, and why you never heat colatura.